Synopsis of recent research by authors named "Katrijn Grupping"
- Katrijn Grupping's research primarily focuses on the immunogenicity, safety, and quality of life impacts related to herpes zoster (HZ) vaccines in older adults, particularly examining the effects of reactogenicity from the recombinant zoster vaccine (RZV) on physical functioning and quality of life.
- Her work includes assessing frailty indices in older populations and their implications for clinical vaccine trials, emphasizing the necessity of evaluating frailty to gauge the benefits and risks of healthcare interventions.
- Additionally, Grupping has explored the coadministration of the HZ vaccine with other vaccines, like the seasonal influenza vaccine, to determine safety and immune response, as well as the efficacy of novel microbicide candidates against HIV transmission, particularly focusing on cellular mechanisms.
